Patients with fluoroquinolone-resistant rectal vault flora appear to have higher odds of developing infectious complications following transrectal ultrasound-guided prostate needle biopsy despite targeted prophylaxis, a study has found.
Twelve weeks of treatment with ledipasvir plus sofosbuvir may yield a sustained virologic response (SVR) of 100 percent in a group of patients coinfected with hepatitis C (HCV) and hepatitis B (HBV) viruses, as reported in a recent study. Most patients may have an increase in HBV DNA level that is not associated with signs or symptoms.
After 10 years of follow-up, a three-dose regimen of the four-valent human papillomavirus vaccine is clinically effective and well-tolerated in adolescents and preadolescents, a recent long-term follow-up study has shown.
In adults presenting to primary care, radiographic confirmation of pneumonia is very uncommon, according to a recent study. In this setting, pulse oximetry and clinical signs may aid the diagnosis of pneumonia.
Flu vaccination continues to be highly recommended for high-risk paediatric populations, with a recent study showing substantial protection among children who received the vaccine and especially in those who were fully vaccinated.
The paediatric dosing of intravenous zanamivir has a safety profile that is consistent with that expected in a population of children hospitalized for severe or progressive influenza, with majority achieving clinical improvement during the treatment course, according to a study.
In patients infected with Helicobacter pylori, long-term use of proton pump inhibitors is associated with an increased risk of gastric cancer even after treatment for the infection, a recent population-based study has shown.
The risks of hepatocellular carcinoma (HCC) and death/transplantation in chronic hepatitis B virus infection appear to be greater in untreated immune-tolerant-phase patients than in treated immune-active-phase patients, a study has found.